157 related articles for article (PubMed ID: 34453383)
21. Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution.
Zeng WG; Zhou ZX; Liang JW; Hou HR; Wang Z; Zhou HT; Zhang XM; Hu JJ
Tumour Biol; 2014 Aug; 35(8):7513-21. PubMed ID: 24789435
[TBL] [Abstract][Full Text] [Related]
22. Breast desmoid tumor after augmentation mammoplasty: two case reports.
Mazzocchi M; Onesti MG; Di Ronza S; Scuderi N
Acta Chir Plast; 2009; 51(3-4):73-8. PubMed ID: 20514891
[TBL] [Abstract][Full Text] [Related]
23. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A
Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621
[TBL] [Abstract][Full Text] [Related]
24. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients.
Peng PD; Hyder O; Mavros MN; Turley R; Groeschl R; Firoozmand A; Lidsky M; Herman JM; Choti M; Ahuja N; Anders R; Blazer DG; Gamblin TC; Pawlik TM
Ann Surg Oncol; 2012 Dec; 19(13):4036-42. PubMed ID: 22972507
[TBL] [Abstract][Full Text] [Related]
25. Desmoid tumour of the breast.
Chummun S; McLean NR; Abraham S; Youseff M
J Plast Reconstr Aesthet Surg; 2010 Feb; 63(2):339-45. PubMed ID: 19059821
[TBL] [Abstract][Full Text] [Related]
26. Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model.
Pinto FFE; Mello CAL; Nakagawa SA; Chung WT; Torrezan GT; Barros BDF; Cunha IW; Calsavara VF; Carraro DM; Lopes A
Clin Orthop Relat Res; 2023 Oct; 481(10):1978-1989. PubMed ID: 37104792
[TBL] [Abstract][Full Text] [Related]
27. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
[TBL] [Abstract][Full Text] [Related]
28. Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence.
Lee KT; Kim S; Jeon BJ; Pyon JK; Mun GH; Ryu JM; Lee SK; Yu J; Kim SW; Lee JE; Nam SJ; Bang SI
JAMA Surg; 2020 Dec; 155(12):1132-1140. PubMed ID: 33026424
[TBL] [Abstract][Full Text] [Related]
29. Do biomaterials cause implant-associated mesenchymal tumors of the breast? Analysis of 8 new cases and review of the literature.
Balzer BL; Weiss SW
Hum Pathol; 2009 Nov; 40(11):1564-70. PubMed ID: 19540553
[TBL] [Abstract][Full Text] [Related]
30. Surgical management of desmoid tumors of the female pelvis.
Mariani A; Nascimento AG; Webb MJ; Sim FH; Podratz KC
J Am Coll Surg; 2000 Aug; 191(2):175-83. PubMed ID: 10945361
[TBL] [Abstract][Full Text] [Related]
31. Risk factors of local recurrence after surgery in extraabdominal desmoid-type fibromatosis: A multicenter study in Japan.
Nishida Y; Hamada S; Kawai A; Kunisada T; Ogose A; Matsumoto Y; Ae K; Toguchida J; Ozaki T; Hirakawa A; Motoi T; Sakai T; Kobayashi E; Gokita T; Okamoto T; Matsunobu T; Shimizu K; Koike H
Cancer Sci; 2020 Aug; 111(8):2935-2942. PubMed ID: 32539220
[TBL] [Abstract][Full Text] [Related]
32. Surgical resection and radiation therapy of desmoid tumours of the extremities: results of a supra-regional tumour centre.
Prodinger PM; Rechl H; Keller M; Pilge H; Salzmann M; von Eisenhart-Rothe R; Holzapfel BM
Int Orthop; 2013 Oct; 37(10):1987-93. PubMed ID: 23793461
[TBL] [Abstract][Full Text] [Related]
33. Role of radiotherapy in the management of desmoid tumors.
Gluck I; Griffith KA; Biermann JS; Feng FY; Lucas DR; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):787-92. PubMed ID: 20615622
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors influencing event-free survival and treatments in desmoid-type fibromatosis: analysis from a large institution.
Huang K; Wang CM; Chen JG; Du CY; Zhou Y; Shi YQ; Fu H
Am J Surg; 2014 Jun; 207(6):847-54. PubMed ID: 24119719
[TBL] [Abstract][Full Text] [Related]
35. Desmoid-type fibromatosis of the breast: A case report.
Bhat D; Wear V; Weisenberg E; Alvarado R
Breast Dis; 2016; 36(4):149-152. PubMed ID: 27612042
[TBL] [Abstract][Full Text] [Related]
36. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series.
Mullen JT; Delaney TF; Kobayashi WK; Szymonifka J; Yeap BY; Chen YL; Rosenberg AE; Harmon DC; Choy E; Yoon SS; Raskin KA; Petur Nielsen G; Hornicek FJ
Ann Surg Oncol; 2012 Dec; 19(13):4028-35. PubMed ID: 22965569
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for second recurrence after surgical resection of recurrent desmoid-type fibromatosis.
Cates JM
Pathol Oncol Res; 2015 Sep; 21(4):1085-90. PubMed ID: 25916970
[TBL] [Abstract][Full Text] [Related]
38. The enigma of desmoid tumors.
Lewis JJ; Boland PJ; Leung DH; Woodruff JM; Brennan MF
Ann Surg; 1999 Jun; 229(6):866-72; discussion 872-3. PubMed ID: 10363901
[TBL] [Abstract][Full Text] [Related]
39. Postoperative recurrence of desmoid tumors: clinical and pathological perspectives.
Wang YF; Guo W; Sun KK; Yang RL; Tang XD; Ji T; Tang S
World J Surg Oncol; 2015 Feb; 13():26. PubMed ID: 25888954
[TBL] [Abstract][Full Text] [Related]
40. A desmoid tumor associated with a ruptured silicone breast implant.
Mátrai Z; Tóth L; Gulyás G; Szabó É; Szentirmay Z; Kásler M
Plast Reconstr Surg; 2011 Jan; 127(1):1e-4e. PubMed ID: 21200191
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
